Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
about
Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertensionCoagulation and the vessel wall in pulmonary embolismDiagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guidelineChronic thromboembolic pulmonary hypertension (CTEPH).Splenectomy and chronic thromboembolic pulmonary hypertension.Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.Up-regulation of urokinase and urokinase receptor genes in malignant astrocytomaChronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy.p75 neurotrophin receptor regulates agonist-induced pulmonary vasoconstriction.Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysisChronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells.Epidemiology and Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: Risk Factors and Mechanisms.Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension.Chronic thromboembolic pulmonary arterial hypertension: a review of the literature and novel therapeutic approaches.From Acute to Chronic Thromboembolic Disease.The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension.Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages.Right ventricular diastolic performance: compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade.Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen.Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
P2860
Q26744048-C0D5E5A1-A66B-4AB5-8481-A303D062937EQ27021049-EE1FDE1A-4FD6-4150-AD38-AD0E3A40D1A0Q34425513-CCDECF8E-F5A2-43F4-B1F5-1DED73928A82Q34663285-924E2814-7CA3-4E3D-8B1C-8E1D5F4A942FQ35537361-1F751D64-7AEA-4AE9-91FD-E135238A3AD4Q35763567-17CA7D64-F607-4224-94A8-DE5E8591D25FQ35795105-8D454769-1DBF-434C-8400-E3B75F6C93D6Q36253030-D0F3CBCE-4066-4ED6-BA00-D73BFD77546CQ36995106-050F011D-79CD-40C0-8AA6-F232B34C54DAQ37144505-2DC22809-5C84-474B-8978-70D9E5CF60B5Q37218023-BABA1825-D490-44AB-AB9C-CD98F855158CQ37691669-4721B5C4-3651-4F42-AA8B-33AE5D141F65Q37717701-5491F4EE-1A9C-49ED-8D67-A8850FE20438Q38479613-0ADFD7C8-4B61-48A9-9363-F213A8A76D31Q38826925-E5F37751-7975-4657-9965-466770AF9148Q38939738-04947FE7-ADC5-47FE-8975-34B668C72ACFQ40853251-EA20A9DA-C435-4573-BEBB-8BEF2E266F10Q41715335-C90E70DD-3AB7-435C-8B8C-9B65747B76E0Q42485943-84BAC706-7B72-42C5-8783-E51013EC9F3BQ47934955-1E5049E6-5753-467E-BC09-04F6B9D29B86Q57166510-DF71DBAE-35A1-45D3-86E9-D8ED3275D08D
P2860
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@en
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@nl
type
label
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@en
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@nl
prefLabel
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@en
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@nl
P2093
P356
P1433
P1476
Endogenous fibrinolytic system ...... mbolic pulmonary hypertension.
@en
P2093
P304
P356
10.1161/01.CIR.86.4.1241
P407
P577
1992-10-01T00:00:00Z